GlassScriptPhysician profile
Kerri C Svanda
NPI 1255505640
$5,043.90
in general payments reported to CMS, 2019-2025
19 companies · $633 in 2025
The $633 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $112 · 2021: $195 · 2022: $262 · 2023: $2,399 · 2024: $1,183 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,462 · Travel and Lodging: $1,728 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,461.87 |
| Travel and Lodging | $1,727.55 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $2,383.04 | 2023-2025 | Visumax, Cirrus Hd-Oct, Clarus |
| Dompe US, INC. | $645.56 | 2019-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $435.90 | 2020-2025 | Cequa |
| Bausch & Lomb Americas INC. | $426.15 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Biotissue Holdings INC. | $171.22 | 2019-2024 | |
| Carl Zeiss Meditec, INC. | $145.35 | 2019 | |
| Glaukos Corporation | $138.06 | 2023-2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
| Rxsight INC | $116.68 | 2022-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Novartis Pharmaceuticals Corporation | $96.47 | 2019-2022 | |
| Alcon Vision LLC | $91.13 | 2022-2025 | Tryptyr, Clareon |
| Abbvie INC. | $83.18 | 2023-2024 | Vuity |
| Tarsus Pharmaceuticals, INC. | $69.03 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $50.46 | 2022-2023 | Tyrvaya |
| Kala Pharmaceuticals, INC. | $46.83 | 2021 | |
| Thea Pharma INC. | $40.11 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akorn Operating Company LLC | $33.61 | 2021 | |
| Aerie Pharmaceuticals, INC. | $26.97 | 2019-2020 | |
| Allergan, INC. | $23.25 | 2020 | |
| Lensar, INC. | $20.90 | 2025 | Lensar Laser System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerri Svanda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.